Columvi

Columvi Warnings and Precautions

• Treatment with Columvi can cause cytokine release syndrome (CRS), including serious or fatal reactions. Patients receive premedication and step-up dosing to reduce risk. Treatment should occur where healthcare professionals can quickly recognize and manage CRS.
• This medicinal product can cause serious neurological complications, including ICANS, which may be life-threatening. Tell your doctor immediately about confusion, headache, tremors, speech difficulties, or changes in alertness. Avoid driving until symptoms completely resolve.
• Columvi may increase the risk of serious, sometimes life-threatening infections. Your doctor may recommend antiviral medicines and regular monitoring. Report signs of infection, including fever, chills, cough, or other unusual symptoms, promptly.
• This medicine can reduce white blood cells, red blood cells, and platelets. Your doctor will regularly check blood counts and may delay, adjust, or temporarily stop treatment if blood cell levels become dangerously low.
• Columvi may cause tumor flare, temporarily worsening cancer-related symptoms, or tumor lysis syndrome (TLS) when cancer cells break down quickly. Your doctor may recommend close monitoring, extra fluids, or medicines to reduce risks.
• Infusion-related reactions may occur during or shortly after Columvi treatment, including fever, chills, dizziness, or blood-pressure changes. Healthcare professionals will monitor you during and after infusion and provide treatment if reactions occur.
• This medicine may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and afterward as advised. Pregnancy should be checked before treatment. Breastfeeding is not recommended during treatment or afterward.
• Columvi must be prepared and administered exactly according to prescribing instructions by trained healthcare professionals. This helps prevent medication errors, supports correct dosing, and ensures the medicine is delivered safely to the patient.

How to Access Columvi in India: A 6-Step Process

• Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
• Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
• Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
• Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
• Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.
• Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Access This Process Easily via Our App

You can manage the entire process seamlessly through the Named Patient Program App, available on both the Play Store and App Store.

• Track your medicine request in real-time
• Upload documents and approvals
• View quotations and timelines
• Get status updates at every step

You can also access detailed information by clicking Login in the website header. On mobile, open the hamburger menu (☰) and tap Login from the dropdown to get started.

Documentation & Availability

What documents are required to import Columvi to India?

Columvi (glofitamab-gxbm) injection may be imported in the patient's name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a qualified oncologist/hematologist
• The patient's diagnostic reports (histopathology, prior lines of therapy, and relevant imaging)
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Columvi available in India?

Columvi (glofitamab-gxbm injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Columvi is not commercially marketed in India.

However, patients in India can legally access Columvi through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of an individual patient, on the prescription of their treating physician.

NamedPatientProgram.com (NPP) acts as a facilitator under named patient supply, providing input on:

• Availability of Columvi in India and pathways to access it
• Availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE)
• Columvi price in India under the NPP route
• Sourcing from genuine, reliable channels in the USA, Europe, China, Singapore, Canada, and Australia
• Ensuring full transparency throughout the process

Columvi can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only upon receipt of a valid doctor's prescription and, where applicable, an import permit.

Sourcing & Delivery of Columvi

NamedPatientProgram.com (NPP) can source Columvi from reliable global manufacturers and qualified pharmaceutical supply channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. As a temperature-sensitive biologic, Columvi requires cold-chain handling throughout transit.

All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Columvi cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Columvi® Across Major Cities in India

Patients across India can access Columvi® through regulated import pathways, with delivery arranged to the treating hospital based on a valid oncologist's prescription.

Mumbai: A major oncology and hematology hub with institutions like Tata Memorial, Mumbai, sees high demand for advanced lymphoma therapies like Columvi®. Access is often coordinated for patients undergoing specialized care for relapsed or refractory DLBCL.

Bangalore: With a growing network of multispecialty hospitals, Bangalore supports access to global oncology treatments through structured import pathways guided by treating specialists.

Delhi: As part of the Delhi NCR region, the city has a strong concentration of cancer centers and hematology specialists, making it a key location for accessing advanced imported therapies.

Gurgaon: Home to leading hospitals like Medanta, Gurgaon plays an important role in facilitating access to innovative lymphoma treatments through coordinated care pathways.

Noida: With proximity to Delhi and access to top hospitals, Noida patients benefit from streamlined logistics and specialist-driven treatment planning.

Hyderabad: Hyderabad's advanced healthcare infrastructure and oncology expertise support patients seeking access to internationally approved lymphoma therapies.

Chennai: Known for its established medical ecosystem, Chennai attracts patients from across India for complex lymphoma treatments and specialized drug access.

Kolkata: A key eastern healthcare hub, Kolkata offers access to advanced oncology care through leading hospitals and treatment centers.

Ahmedabad: Ahmedabad's expanding healthcare sector and oncology facilities support patients requiring advanced and imported cancer therapies.

Pune: With reputed hospitals and a growing cancer care infrastructure, Pune is an emerging center for access to specialized oncology treatments.

Chandigarh: Serving North India, Chandigarh provides access to advanced medical care through reputed institutions and specialist-led treatment planning.

Jaipur: Jaipur's improving healthcare network enables patients to explore access to innovative lymphoma therapies through structured import processes.

Lucknow: As a major city in North India, Lucknow supports access to advanced oncology treatments through both public and private healthcare institutions.

Indore: Indore is emerging as a regional healthcare hub, offering access to specialized cancer care and modern treatment pathways.

Bhopal: Patients in Bhopal can access advanced cancer treatments through the growing healthcare infrastructure and referral networks.

Nagpur: Nagpur serves as a central hub for patients across Vidarbha, with increasing access to oncology care and specialized therapies.

Surat: Surat's developing healthcare ecosystem supports patients seeking access to global oncology treatments through coordinated care.

Patna: As a major city in Eastern India, Patna provides growing access to cancer treatment through expanding hospital networks.

Coimbatore: Coimbatore is known for quality healthcare services, offering access to advanced oncology treatments in South India.

Kochi: With modern hospitals and specialist care, Kochi enables patients to explore access to internationally approved cancer therapies.

Note: Access timelines may vary depending on documentation, regulatory approvals, and sourcing logistics.

Access/Buy Columvi® at Leading Hospitals in India

Columvi® is typically used in advanced hematology-oncology settings and can be accessed at leading hospitals across India, where specialists guide treatment decisions and coordinate patient-specific access pathways.

Major Hospitals Covered:

• Tata Memorial Centre: One of India's premier cancer institutes, Tata Memorial plays a key role in treating complex lymphoma cases and guiding patients toward advanced therapies like Columvi®.
• AIIMS: As a leading government medical institution, AIIMS provides comprehensive cancer care and supports patients requiring access to specialized and emerging treatments.
• Apollo Hospitals: With a nationwide presence, Apollo Hospitals offers advanced oncology services and facilitates access to global treatment options through its extensive medical network.
• Fortis Healthcare: Fortis hospitals are equipped with modern cancer care facilities and multidisciplinary teams that manage complex treatment pathways for patients.
• Max Healthcare: Max Healthcare is known for its strong oncology and hematology departments, providing access to innovative therapies under expert clinical supervision.
• Manipal Hospitals: Manipal Hospitals supports advanced cancer care through experienced specialists and structured treatment planning across multiple cities.
• Kokilaben Dhirubhai Ambani Hospital: A leading private hospital in Mumbai, Kokilaben Hospital offers cutting-edge oncology care and access to advanced global therapies.
• Medanta – The Medicity: Medanta is a renowned super-specialty hospital where complex lymphoma cases are managed with advanced treatment protocols and global access support.
• BLK-Max Super Speciality Hospital: BLK-Max provides comprehensive oncology and bone marrow transplant services and supports patients seeking access to specialized treatment options.
• Rajiv Gandhi Cancer Institute: A dedicated cancer care center, RGCI focuses on advanced oncology treatments and supports patients through complex treatment journeys.
• HCG Cancer Centre: HCG is a specialized cancer hospital network known for its focus on precision oncology and advanced treatment modalities.
• Narayana Health: Narayana Health combines affordability with advanced medical care, offering oncology services across multiple locations in India.
• Amrita Hospital: Amrita Hospital provides high-quality cancer care with a focus on patient-centric treatment and access to modern therapies.
• Sir Ganga Ram Hospital: A well-established hospital in Delhi, Sir Ganga Ram provides multidisciplinary cancer care supported by experienced specialists.
• Ruby Hall Clinic: Ruby Hall Clinic offers comprehensive cancer care and supports patients requiring advanced and imported therapies.
• CARE Hospitals: CARE Hospitals provide modern oncology treatment facilities and multidisciplinary care across multiple cities.

Note: Columvi® is not stocked for direct purchase but is arranged through compliant import processes and delivered to the hospital for patient-specific treatment.